Valuation: Alkem Laboratories Limited

Market Cap 64TCr 666.91Cr 582.32Cr 547.2Cr 499.83Cr 937.96Cr 937.58Cr 6.56TCr 2.53TCr 33TCr 2.5TCr 2.45TCr 1,05000Cr P/E 2027 *
27.8x
P/E 2028 * 24.2x
Enterprise Value 62TCr 653.23Cr 570.37Cr 535.97Cr 489.58Cr 918.71Cr 918.34Cr 6.42TCr 2.48TCr 32TCr 2.45TCr 2.4TCr 1,02800Cr EV / Sales 2027 *
3.74x
EV / Sales 2028 * 3.28x
Free-Float
37.56%
Yield 2027 *
0.93%
Yield 2028 * 1.04%
1 day-0.24%
1 week+4.87%
Current month-0.30%
1 month-1.12%
3 months-0.70%
6 months+1.51%
Current year-3.05%
1 week 5,149.45
Extreme 5149.45
5,501.6
1 month 5,052.05
Extreme 5052.05
5,501.6
Current year 5,052.05
Extreme 5052.05
5,933
1 year 5,052.05
Extreme 5052.05
5,933
3 years 3,440.05
Extreme 3440.05
6,440
5 years 2,835
Extreme 2835
6,440
10 years 1,400
Extreme 1400
6,440
Manager TitleAgeSince
President - -
President - -
Director of Finance/CFO - 01/02/2024
Director TitleAgeSince
Director/Board Member 44 09/08/2013
Director/Board Member 63 11/02/2008
Director/Board Member 45 11/11/2019
Change 5-day change 1-year change 3-year change Capi.($)
-0.24%+4.87% - - 669.45Cr
+0.45%+2.80%+55.61%+112.70% 1,03800Cr
-0.10%+1.08%+52.78%+66.52% 65TCr
+0.28%+1.31%+19.21%+72.85% 47TCr
-0.19%+0.75%+37.34%+45.03% 36TCr
+0.28%+2.23%+19.12%+25.62% 27TCr
+0.89%+4.26%+12.10%+16.41% 26TCr
+4.34%+7.53%+43.74%+52.27% 21TCr
-0.46%-7.70%-33.40%-59.71% 18TCr
+1.40%+4.28%+33.82%+102.83% 19TCr
Average +0.44%+1.04%+26.70%+48.28% 40.17TCr
Weighted average by Cap. +0.37%+1.47%+36.59%+66.72%

Financials

2027 *2028 *
Net sales 17TCr 174.71Cr 152.55Cr 143.35Cr 130.94Cr 245.72Cr 245.62Cr 1.72TCr 663.23Cr 8.53TCr 656.12Cr 641.67Cr 27TCr 19TCr 194.3Cr 169.66Cr 159.42Cr 145.62Cr 273.27Cr 273.16Cr 1.91TCr 737.59Cr 9.49TCr 729.68Cr 713.62Cr 31TCr
Net income 2.31TCr 24Cr 21Cr 20Cr 18Cr 34Cr 34Cr 238.02Cr 92Cr 1.18TCr 91Cr 89Cr 3.81TCr 2.72TCr 28Cr 25Cr 23Cr 21Cr 40Cr 40Cr 279.27Cr 107.84Cr 1.39TCr 106.68Cr 104.33Cr 4.47TCr
Net Debt -1.31TCr -14Cr -12Cr -11Cr -10Cr -19Cr -19Cr -134.52Cr -52Cr -668.11Cr -51Cr -50Cr -2.15TCr -2.81TCr -29Cr -26Cr -24Cr -22Cr -41Cr -41Cr -288.58Cr -111.43Cr -1.43TCr -110.24Cr -107.81Cr -4.62TCr
Logo Alkem Laboratories Limited
Alkem Laboratories Ltd. is an India-based pharmaceutical company engaged in the development, manufacturing, and sale of pharmaceutical products. The Company operates in a single business segment-Pharmaceuticals. It produces branded generics, generic drugs, active pharmaceutical ingredients (APIs), and nutraceuticals, which it markets in India and international markets. It has a portfolio of approximately 800 brands in India and maintains a presence in over 40 international markets, with the United States being its key focus market. Its offerings include therapies, prescription (Rx) products, and Alkem generics. Its therapy offerings cover multiple medical fields, including anti-infectives, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory care, rheumatology, and urology. The Company’s subsidiaries include Ascend Laboratories (Pty) Ltd, Pharmacor Pty Limited, Alkem Laboratories Corporation, and others.
Employees
19,346
Date Price Change Volume
22/26/22 ₹5,337.15 -0.24% 805
21/26/21 ₹5,350.00 -2.76% 3,638
18/26/18 ₹5,501.60 +3.03% 25,104
17/26/17 ₹5,340.00 +2.91% 5,586
16/26/16 ₹5,188.95 +0.66% 53,758
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
5,331.50INR
Average target price
5,948.55INR
Spread / Average Target
+11.57%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!